European Companies Search Engine
EU funding (€1,999,933): Alliance for Life Sciences: From Strategies to Actions in Central and Eastern Europe Hor 17 Dec 2020 EU Research and Innovation programme "Horizon"
Text
Alliance for Life Sciences: From Strategies to Actions in Central and Eastern Europe
The gap in Research and Innovation (R&I) performance, which persists despite considerable investments from the European Structural and Investment Funds (ESIF) in the lower-performing regions of the EU, is an issue with major socio-economic and political consequences. In Health R&I the gap has a profound impact on distribution of funding from the EU Framework Programmes as well as on hindering the EU-wide impact of R&I on health and quality of life. With A4L_ACTIONS, we aim to address roots of this situation in the lower-performing Central and Eastern Europe (CEE) by improving culture, governance, recognition and innovation potential of the health research-performing institutions. Our goal is to increase their attractiveness for collaborations with advanced Europe and create spill-over effects in the whole region. As the Alliance4Life, we are an established network of progressive health research institutions in CEE and a source of successfully piloted good practice. By building upon our results and impact achieved so far, we will convert our recommendations and strategies into actions as follows: - Culture fostering excellence: piloting peer-evaluation and assessment of institutional practice as a strategic management tool, professionalizing research administration; - Recognition and trust towards CEE: attracting advanced partners to identified pockets of excellence, supporting scientific ideas originating in CEE, initiating new international projects and collaborations with industry; - Career policy nurturing talent: training and networking next generation of leaders, upgrading institutional career systems; - Impact on innovation: raising the competences of Technology Transfer specialists, creating industry relations platform linking academia and industry; - Spill-over effects: sharing, inspiring, communicating with stakeholders and policy makers; using the established networks to gain advice, new collaborations and EU-wide impact.
Funded Companies:
| Company name | Funding amount |
| Biomedicinske Centrum Slovenskej Akademie Vied, Verejna Vyskumna Institucia | €149,538 |
| Fakultni Nemocnice U SV Anny V Brne | €124,294 |
| Latvijas Organiskas Sintezes Instituts | €155,913 |
| Masarykova Univerzita | €561,476 |
| Medical University Sofia | €74,413 |
| Semmelweis Egyetem | €148,169 |
| Sveuciliste U Zagrebu Medicinski Fakultet | €155,788 |
| Tartu Ulikool | €140,938 |
| Universitatea de Medicina si Farmacie Carol Davila Din Bucuresti | €97,038 |
| Univerza V Ljubljani | €114,663 |
| Uniwersytet Medyczny w Lodzi | €146,919 |
| Vilniaus Universitetas | €130,788 |
Source: https://cordis.europa.eu/project/id/964997
The filing refers to a past date, and does not necessarily reflect the current state.